Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 SGD | +3.85% | +1.89% | 0.00% |
Mar. 12 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
Mar. 12 | Kingsmen Creatives Unit to Sell Malaysia Property; Shares Slip 4% | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 99.79 | 87.85 | 51.5 | 51.5 | 53.52 | 54.53 |
Enterprise Value (EV) 1 | 55.71 | 63.53 | 12.47 | 2.776 | 3.742 | 11.21 |
P/E ratio | 12.2 x | 169 x | -4.63 x | 51.3 x | 11.5 x | 19.2 x |
Yield | 5% | 2.3% | - | - | 3.77% | 3.7% |
Capitalization / Revenue | 0.28 x | 0.24 x | 0.18 x | 0.19 x | 0.16 x | 0.15 x |
EV / Revenue | 0.15 x | 0.17 x | 0.04 x | 0.01 x | 0.01 x | 0.03 x |
EV / EBITDA | 4.93 x | 12.6 x | -4.39 x | 5.24 x | 0.74 x | 2.26 x |
EV / FCF | -4.69 x | -18.1 x | 1.72 x | 1.04 x | 3.61 x | -2.13 x |
FCF Yield | -21.3% | -5.53% | 58.3% | 96.1% | 27.7% | -46.8% |
Price to Book | 0.82 x | 0.76 x | 0.49 x | 0.47 x | 0.49 x | 0.5 x |
Nbr of stocks (in thousands) | 199,575 | 201,948 | 201,948 | 201,948 | 201,948 | 201,948 |
Reference price 2 | 0.5000 | 0.4350 | 0.2550 | 0.2550 | 0.2650 | 0.2700 |
Announcement Date | 4/8/19 | 4/11/20 | 4/7/21 | 4/6/22 | 4/11/23 | 4/11/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 360.9 | 365.9 | 287 | 273.2 | 328.4 | 361.5 |
EBITDA 1 | 11.31 | 5.028 | -2.842 | 0.53 | 5.074 | 4.949 |
EBIT 1 | 7.639 | 0.525 | -8.197 | -4.163 | 1.514 | 1.461 |
Operating Margin | 2.12% | 0.14% | -2.86% | -1.52% | 0.46% | 0.4% |
Earnings before Tax (EBT) 1 | 11.1 | 2.174 | -9.194 | 1.049 | 5.718 | 3.093 |
Net income 1 | 8.154 | 0.518 | -11.12 | 1.004 | 4.637 | 2.857 |
Net margin | 2.26% | 0.14% | -3.87% | 0.37% | 1.41% | 0.79% |
EPS 2 | 0.0409 | 0.002570 | -0.0550 | 0.004971 | 0.0230 | 0.0141 |
Free Cash Flow 1 | -11.89 | -3.515 | 7.265 | 2.669 | 1.036 | -5.249 |
FCF margin | -3.29% | -0.96% | 2.53% | 0.98% | 0.32% | -1.45% |
FCF Conversion (EBITDA) | - | - | - | 503.51% | 20.43% | - |
FCF Conversion (Net income) | - | - | - | 265.8% | 22.35% | - |
Dividend per Share 2 | 0.0250 | 0.0100 | - | - | 0.0100 | 0.0100 |
Announcement Date | 4/8/19 | 4/11/20 | 4/7/21 | 4/6/22 | 4/11/23 | 4/11/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 44.1 | 24.3 | 39 | 48.7 | 49.8 | 43.3 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -11.9 | -3.52 | 7.27 | 2.67 | 1.04 | -5.25 |
ROE (net income / shareholders' equity) | 6.04% | 0.41% | -8.99% | -0.13% | 3.74% | 0.68% |
ROA (Net income/ Total Assets) | 1.77% | 0.11% | -1.86% | -1.01% | 0.37% | 0.34% |
Assets 1 | 461.4 | 458.4 | 596.9 | -99.21 | 1,268 | 830.8 |
Book Value Per Share 2 | 0.6100 | 0.5700 | 0.5200 | 0.5400 | 0.5400 | 0.5400 |
Cash Flow per Share 2 | 0.4000 | 0.3200 | 0.4000 | 0.4000 | 0.3800 | 0.3300 |
Capex 1 | 18.5 | 9.71 | 2.62 | 0.67 | 1.84 | 1 |
Capex / Sales | 5.11% | 2.65% | 0.91% | 0.25% | 0.56% | 0.28% |
Announcement Date | 4/8/19 | 4/11/20 | 4/7/21 | 4/6/22 | 4/11/23 | 4/11/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 40.01M | |
+11.32% | 1.26B | |
-13.67% | 803M | |
-31.72% | 375M | |
-10.95% | 337M | |
-0.62% | 320M | |
-0.11% | 265M | |
-30.27% | 233M | |
-56.20% | 123M | |
+8.89% | 122M |
- Stock Market
- Equities
- 5MZ Stock
- Financials Kingsmen Creatives Ltd.